Safety and Effectiveness of Rasagiline in Chinese Patients with Parkinson’s Disease: A Prospective, Multicenter, Non-interventional Post-marketing Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Effectiveness of Rasagiline in Chinese Patients with Parkinson’s Disease: A Prospective, Multicenter, Non-interventional Post-marketing Study

Published:2023-05-17 Issue:7 Volume:46 Page:637-646
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Su Wen,Liang Zhanhua,Mao Wei,Shao Ming,Hu Xingyue,Wu Yuncheng,Wei Wenshi,Liu Zhenguo,Zhang Kezhong,Tang Beisha,Cao Shuai,Song Zhuolun,Chen Haibo

Funder

H. Lundbeck A/S

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

https://link.springer.com/content/pdf/10.1007/s40264-023-01288-2.pdf

Reference20 articles.

1. Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386:896–912.

2. Todorova A, Jenner P, Ray CK. Non-motor Parkinson’s: integral to motor Parkinson’s, yet often neglected. Pract Neurol. 2014;14:310–22.

3. Qi S, Yin P, Wang L, Qu M, Kan GL, Zhang H, et al. Prevalence of Parkinson’s disease: a community-based study in China. Mov Disord. 2021;36:2940–4.

4. Benazzouz A, Mamad O, Abedi P, Bouali-Benazzouz R, Chetrit J. Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson’s disease. Front Aging Neurosci. 2014;6:87.

5. Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, et al. International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson’s disease. Mov Disord. 2018;33:1248–66.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP